In colorectal carcinoma, the efficacy of immune checkpoint therapy has been limited. 2, 4, 5, 9, 10 It was confirmed only recently that colorectal carcinomas with proficient mismatch-repair function, ...
Data presented by the FDA at the 2017 American Society of Clinical Oncology Annual Meeting identified a need for educating community-based oncology practices on testing for programmed death-ligand 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback